CLDX
Celldex Therapeutics Inc
NASDAQ: CLDX · HEALTHCARE · BIOTECHNOLOGY
$32.14
-3.28% today
Updated 2026-04-29
Market cap
$2.52B
P/E ratio
—
P/S ratio
1,632.24x
EPS (TTM)
$-3.90
Dividend yield
—
52W range
$18 – $36
Volume
1.1M
Celldex Therapeutics Inc (CLDX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $27.00M | $-19.30M | $18.28M | $-29.87M | $-30.37M | $-35.66M | $-49.78M | $-67.67M | $-101.54M | $-98.89M | $-113.04M | $-99.93M | $-75.23M | $-46.41M | $-40.40M | $-60.91M | $-103.73M | $-107.29M | $-157.78M | $-210.94M |
| Capital expenditures | $9.32M | $4.98M | $1.30M | $528000.00 | $2.10M | $509000.00 | $303000.00 | $4.22M | $1.93M | $4.88M | $2.75M | $1.79M | $813000.00 | $731000.00 | $1.55M | $1.25M | $1.83M | $1.82M | $1.92M | $2.71M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.63B | $359.54M | $4.82B | $3.06M | $2.80M | $2.34M | $2.30M | $4.55M | $6.85M | $12.77M | $15.32M | $12.31M | $8.08M | $4.55M | $3.92M | $8.95M | $15.61M | $23.89M | $34.24M | $36.22M |
| Free cash flow | $17.68M | $-24.28M | $16.98M | $-30.40M | $-32.47M | $-36.17M | $-50.09M | $-71.89M | $-103.47M | $-103.76M | $-115.79M | $-101.72M | $-76.05M | $-47.15M | $-41.96M | $-62.16M | $-105.56M | $-109.11M | $-159.70M | $-213.66M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-9.39M | $13.00M | $144.50M | $-141.38M | $44.09M | $-29.65M | $-2.17M | $-15.98M | $-13.08M | $32.60M | $-4.69M | — | — | — | — |